,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,4.26986513522316e-09,3.51409900628866e-06
2,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,1.03184301264322e-08,4.24603399702684e-06
3,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,5.60706617819923e-08,1.53820515488599e-05
4,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,1.18759204400737e-07,2.44347063054517e-05
5,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Down,2.05822937289489e-05,0.0031490635042582
6,WP_COMPLEMENT_ACTIVATION,14,Up,2.38891772170669e-05,0.0031490635042582
7,WP_ZINC_HOMEOSTASIS,24,Up,2.67842582379191e-05,0.0031490635042582
8,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,4.07220358473501e-05,0.00418927943779615
9,WP_MEVALONATE_PATHWAY,7,Down,7.89579488114031e-05,0.00660804705891325
10,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,8.0292187836127e-05,0.00660804705891325
11,WP_ESTROGEN_METABOLISM_WP5276,10,Up,0.000207107990252556,0.0154954432707139
12,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.000287230583123913,0.019699230825915
13,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.000519604316415636,0.0328949501853899
14,WP_IRINOTECAN_PATHWAY,5,Up,0.00068754813754682,0.0404180083715024
15,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.000870368877630808,0.0452498754418722
16,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.000925057682585644,0.0452498754418722
17,WP_G13_SIGNALING,30,Down,0.000971493443495082,0.0452498754418722
18,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,31,Down,0.00098966920772017,0.0452498754418722
19,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,63,Up,0.00144974054144358,0.0601732784443607
20,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.00146229109220804,0.0601732784443607
21,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.00176169729672645,0.0690417559621843
22,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.00212419390100532,0.0794641627512445
23,WP_MICROTUBULE_CYTOSKELETON_REGULATION,36,Down,0.00235717805505021,0.0825811576883766
24,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.00240819900913857,0.0825811576883766
25,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.00261200432273247,0.0859871823043528
26,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Down,0.00295002852709925,0.093379749146257
27,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.00386162499464067,0.116596207610574
28,WP_NEURAL_CREST_DIFFERENTIATION,41,Down,0.00396682115807543,0.116596207610574
29,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.00423045936807841,0.12005751930788
30,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.00457604910009486,0.120250979924074
31,WP_TAMOXIFEN_METABOLISM,2,Up,0.00457936362282958,0.120250979924074
32,WP_COMPLEMENT_SYSTEM,55,Up,0.00467561525828719,0.120250979924074
33,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.00507186309701399,0.122107383086917
34,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.00517817162660412,0.122107383086917
35,WP_VITAMIN_A1_AND_A5X_PATHWAYS,4,Down,0.00522758375366526,0.122107383086917
36,WP_IRON_METABOLISM_IN_PLACENTA,10,Up,0.00552266490595872,0.122107383086917
37,WP_16P112_DISTAL_DELETION_SYNDROME,24,Up,0.00603059642278162,0.122107383086917
38,WP_GABA_RECEPTOR_SIGNALING,10,Down,0.00604606559122933,0.122107383086917
39,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.00616316452821845,0.122107383086917
40,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,49,Down,0.00616891600575209,0.122107383086917
41,WP_GASTRIN_SIGNALING,95,Down,0.00617505350933081,0.122107383086917
42,WP_NEUROINFLAMMATION,10,Down,0.00623148249046233,0.122107383086917
43,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.00679336002260474,0.130021751130319
44,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,2,Down,0.00713674175360387,0.133489510527636
45,WP_SPINAL_CORD_INJURY,69,Down,0.00740549120560918,0.13543820582703
46,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.00789692208450542,0.141286236424956
47,WP_BENZOAPYRENE_METABOLISM,5,Up,0.00889713896508586,0.148471923425064
48,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.00901266392656409,0.148471923425064
49,WP_COMPLEMENT_AND_COAGULATION_CASCADES,31,Up,0.00918122641386213,0.148471923425064
50,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,31,Up,0.00918122641386213,0.148471923425064
51,WP_PROSTAGLANDIN_SIGNALING,23,Down,0.009535199189015,0.148471923425064
52,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,10,Up,0.00956473551816538,0.148471923425064
53,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.0096018406806857,0.148471923425064
54,WP_PPAR_SIGNALING,39,Up,0.0098025723094252,0.148471923425064
55,WP_PDGF_PATHWAY,37,Down,0.0100523805308417,0.148471923425064
56,WP_EBOLA_VIRUS_INFECTION_IN_HOST,109,Down,0.0101025853120335,0.148471923425064
57,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.0109784317339584,0.158513145913119
58,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Down,0.0114081175769535,0.161877254583323
59,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,19,Down,0.0116324176091335,0.162262367666388
60,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.0122638955092066,0.168219766734618
61,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Down,0.0132691059627669,0.176486123839527
62,WP_NRF2_PATHWAY,76,Up,0.0132954309575342,0.176486123839527
63,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,29,Down,0.0135600666697296,0.177141823320435
64,WP_MATRIX_METALLOPROTEINASES,8,Up,0.0138400274359589,0.177974102809284
65,WP_WNT_SIGNALING_WP428,61,Down,0.0141759383427472,0.179489188555092
66,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.0155200526116934,0.193530353021571
67,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.0168727616364998,0.207257952639393
68,WP_WNT_SIGNALING_WP363,39,Down,0.0175506999618692,0.212023080158405
69,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.0184824779149287,0.212023080158405
70,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0185260613892624,0.212023080158405
71,WP_HYPERTROPHY_MODEL,14,Down,0.0186116831281791,0.212023080158405
72,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,42,Down,0.0186753796721446,0.212023080158405
73,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Down,0.0189723313697435,0.212023080158405
74,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.0190640436594434,0.212023080158405
75,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.0193756952124739,0.212615962131547
76,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.0206362775950631,0.219839677387069
77,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.0207156182686631,0.219839677387069
78,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.0209623772504217,0.219839677387069
79,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0211024720699616,0.219839677387069
80,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.0219205710833259,0.225507875019715
81,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.0237147294156494,0.240953361840488
82,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.0242790985258854,0.241564183375457
83,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.0243618799758966,0.241564183375457
84,WP_NOTCH_SIGNALING_WP268,36,Down,0.0247205738849348,0.242202765563111
85,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,107,Down,0.0258207641108749,0.248793785250613
86,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.0262365597666193,0.248793785250613
87,WP_VITAMIN_B12_METABOLISM,27,Up,0.026300193580563,0.248793785250613
88,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.0275145856340259,0.25732390882731
89,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.0287642732575476,0.26317694555512
90,WP_EGFEGFR_SIGNALING,143,Down,0.0289389070463958,0.26317694555512
91,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.0291898402236255,0.26317694555512
92,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.0295844140786334,0.26317694555512
93,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Down,0.0297393146253052,0.26317694555512
94,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.030450272973479,0.263432205198989
95,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,25,Down,0.0307026885446632,0.263432205198989
96,WP_MAPK_SIGNALING,166,Down,0.0308198226560246,0.263432205198989
97,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.0310485102117885,0.263432205198989
98,WP_GPCRS_OTHER,17,Down,0.033624118404202,0.277343506728429
99,WP_ERBB_SIGNALING,69,Down,0.033989924833333,0.277343506728429
100,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.0340164330103185,0.277343506728429
101,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.0346862847144865,0.277343506728429
102,WP_HEART_DEVELOPMENT,19,Down,0.034759394719399,0.277343506728429
103,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,14,Down,0.0349084157110271,0.277343506728429
104,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.0350470530981246,0.277343506728429
105,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,71,Down,0.0375098877503572,0.294006072557562
106,WP_SPHINGOLIPID_PATHWAY,21,Down,0.0383945265978773,0.295884433871793
107,WP_PANCREATIC_CANCER_SUBTYPES,6,Up,0.0384685715969403,0.295884433871793
108,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.0409600071919518,0.305608583161661
109,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,23,Down,0.0415683910492479,0.305608583161661
110,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.0416586351672618,0.305608583161661
111,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Up,0.0418481687986293,0.305608583161661
112,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.0418714012602818,0.305608583161661
113,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,50,Down,0.0422996453034119,0.305608583161661
114,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,62,Down,0.0424906569653232,0.305608583161661
115,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.0427035079752017,0.305608583161661
116,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,21,Down,0.0436784518239849,0.309891084923617
117,WP_P38_MAPK_SIGNALING,31,Down,0.044186597935042,0.31081683846615
118,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.0455692554775752,0.312256859383279
119,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.0456924197232347,0.312256859383279
120,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,57,Down,0.0458151614793637,0.312256859383279
121,WP_NRF2ARE_REGULATION,20,Up,0.0459089671754275,0.312256859383279
122,WP_FERROPTOSIS,52,Up,0.0465188382537968,0.313811507236678
123,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,16,Up,0.0486517759719973,0.323779334817957
124,WP_COPPER_HOMEOSTASIS,40,Up,0.0487832776639449,0.323779334817957
125,WP_FTO_OBESITY_VARIANT_MECHANISM,3,Up,0.0499243089849982,0.326455370954437
126,WP_CHOLESTEROL_METABOLISM,53,Down,0.0499798016285043,0.326455370954437
127,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1,Down,0.0524096523761732,0.337209379129598
128,WP_MAPK_CASCADE,30,Down,0.0524456871550287,0.337209379129598
129,WP_15Q25_COPY_NUMBER_VARIATION,29,Up,0.0546259267358497,0.34568818605915
130,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.0547087781958377,0.34568818605915
131,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.0550244864808611,0.34568818605915
132,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,16,Down,0.0561303818738033,0.349964426379849
133,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.057578169154139,0.353917163240581
134,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,15,Down,0.057624422690447,0.353917163240581
135,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,50,Down,0.0587704525285073,0.354163045710899
136,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,33,Down,0.0592006075092486,0.354163045710899
137,WP_SEROTONIN_AND_ANXIETY,7,Down,0.0595352667493294,0.354163045710899
138,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,14,Down,0.0598134641545207,0.354163045710899
139,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.0599933532137071,0.354163045710899
140,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Down,0.0602464476300436,0.354163045710899
141,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.0621915936403948,0.363004833801737
142,WP_INSULIN_SIGNALING,132,Down,0.0634678166111963,0.367293478023467
143,WP_PPARALPHA_PATHWAY,15,Up,0.0641039240239981,0.367293478023467
144,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.0642652015010683,0.367293478023467
145,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.0651738840700814,0.369917976480531
146,WP_MONOAMINE_GPCRS,3,Down,0.0671916808759729,0.375785759605542
147,WP_OSTEOBLAST_SIGNALING,3,Down,0.0671998321453799,0.375785759605542
148,WP_POSTCOVID_NEUROINFLAMMATION,14,Down,0.0679574861746746,0.375785759605542
149,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.068034116866617,0.375785759605542
150,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.068724390114168,0.377067820426402
151,WP_AXON_GUIDANCE,39,Down,0.0703578397495093,0.383473523932756
152,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.0729957371297865,0.39476921823875
153,WP_PLEURAL_MESOTHELIOMA,262,Down,0.0733896602558065,0.39476921823875
154,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.0746364505310052,0.398391213558067
155,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0751090113395714,0.398391213558067
156,WP_FOCAL_ADHESION,123,Down,0.0759772363706317,0.398391213558067
157,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.0759992959035437,0.398391213558067
158,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.0770720023634321,0.400249537630946
159,WP_MACROPHAGE_MARKERS,9,Up,0.0773264598825278,0.400249537630946
160,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,77,Down,0.0780734307248407,0.4015902092909
161,WP_IL1_SIGNALING,54,Down,0.0792153736893398,0.403219576489544
162,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0793700745945397,0.403219576489544
163,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.0808142068972966,0.408037375929295
164,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.0814987419143719,0.408984540216635
165,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.0825944266369075,0.410706866437379
166,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.0828400240930802,0.410706866437379
167,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.0840403583300595,0.413733123016393
168,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Down,0.0844558501418639,0.413733123016393
169,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.0865020727368162,0.419982870069498
170,WP_PDGFRBETA_PATHWAY,28,Down,0.0867522331856801,0.419982870069498
171,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.0891239270446386,0.428941473437062
172,WP_KLEEFSTRA_SYNDROME,25,Down,0.0906318329558508,0.433049206335298
173,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.091029784563799,0.433049206335298
174,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.0931665234257122,0.440666947007822
175,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.0961354724850753,0.448904872930757
176,WP_BENZENE_METABOLISM,4,Up,0.0962883233480637,0.448904872930757
177,WP_HISTONE_MODIFICATIONS,37,Up,0.0965445473982307,0.448904872930757
178,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.0982930585434881,0.454467343715116
179,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.100914438547835,0.462222630117937
180,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.101093649357507,0.462222630117937
181,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.108734896276065,0.491965015256253
182,WP_BREAST_CANCER_PATHWAY,90,Down,0.108794207505028,0.491965015256253
183,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.110802151268081,0.498306942588147
184,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Down,0.113539060236836,0.504585210611187
185,WP_FOLATE_METABOLISM,40,Up,0.113922365955131,0.504585210611187
186,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.115394651811878,0.504585210611187
187,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.115586143615517,0.504585210611187
188,WP_NOTCH_SIGNALING_WP61,50,Down,0.116034308155192,0.504585210611187
189,WP_B_CELL_RECEPTOR_SIGNALING,88,Down,0.116264558890548,0.504585210611187
190,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Up,0.117124314978155,0.504585210611187
191,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.117523879394937,0.504585210611187
192,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.117742895807628,0.504585210611187
193,WP_IRON_METABOLISM_DISORDERS,14,Up,0.118329217069209,0.504585210611187
194,WP_NPHP1_DELETION_SYNDROME,10,Down,0.119307110570159,0.505341681215776
195,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.119762042311654,0.505341681215776
196,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,8,Up,0.120348687142518,0.505341681215776
197,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,22,Down,0.122502202360196,0.511773160113916
198,WP_NUCLEAR_RECEPTORS,21,Down,0.123732577766109,0.51345956345089
199,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,64,Down,0.124153648999668,0.51345956345089
200,WP_LEPTIN_SIGNALING,70,Down,0.125427096350006,0.513804126981702
201,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.126940646839924,0.513804126981702
202,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.12781355646715,0.513804126981702
203,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.127895199559483,0.513804126981702
204,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.128487351229735,0.513804126981702
205,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.128487351229735,0.513804126981702
206,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,54,Down,0.128607108333209,0.513804126981702
207,WP_DOPAMINE_METABOLISM,7,Up,0.13032977904424,0.518171053881207
208,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.131484997175272,0.520250734015618
209,WP_BARDETBIEDL_SYNDROME,65,Up,0.133149404972562,0.524315599485257
210,WP_SMALL_LIGAND_GPCRS,7,Down,0.134350864649131,0.526287481607304
211,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Down,0.134929111323379,0.526287481607304
212,WP_CYTOSINE_METHYLATION,7,Down,0.136628382616843,0.528396422551622
213,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,10,Down,0.13681405746716,0.528396422551622
214,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,44,Down,0.13739591060273,0.528396422551622
215,WP_NAD_METABOLISM,12,Down,0.139874067942845,0.535424920544005
216,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.141276259720044,0.538288711803688
217,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,30,Down,0.142453768720161,0.54027397076817
218,WP_AMINO_ACID_METABOLISM,60,Up,0.144167436184393,0.542925227717533
219,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Down,0.144472205188505,0.542925227717533
220,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,33,Down,0.145551198232872,0.544493800662061
221,WP_HEPATITIS_B_INFECTION,121,Down,0.146428895825849,0.545298557758706
222,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.147562245106434,0.547043818570247
223,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Up,0.148440271614505,0.547831136945014
224,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.149210126792054,0.548213992633304
225,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.150695040562179,0.549505213574337
226,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,16,Down,0.150896935926853,0.549505213574337
227,WP_TRYPTOPHAN_METABOLISM,19,Up,0.1524782635011,0.550509740726276
228,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.152510596458798,0.550509740726276
229,WP_OREXIN_RECEPTOR_PATHWAY,122,Down,0.154133179980209,0.553937149011844
230,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,46,Down,0.158241889143364,0.564833263167795
231,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.158537647377595,0.564833263167795
232,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.159528887357283,0.565914975409673
233,WP_FRAGILE_X_SYNDROME,86,Down,0.16322981233682,0.576558521687565
234,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.164610871976534,0.578951912977297
235,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.166237580372457,0.579608709520075
236,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Up,0.16695092769621,0.579608709520075
237,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.167880923945345,0.579608709520075
238,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Down,0.168410440404044,0.579608709520075
239,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.168975045606534,0.579608709520075
240,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,81,Down,0.170009789672613,0.579608709520075
241,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.171110315256373,0.579608709520075
242,WP_IL9_SIGNALING,15,Up,0.171116590001165,0.579608709520075
243,WP_KININKALLIKREIN_PATHWAY,3,Up,0.17113598592148,0.579608709520075
244,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Up,0.173579653237955,0.581217488406127
245,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Down,0.173698716425239,0.581217488406127
246,WP_PEPTIDE_GPCRS,15,Down,0.174318501523431,0.581217488406127
247,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.174435868330879,0.581217488406127
248,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.177024241462792,0.583198655465592
249,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.177104358168286,0.583198655465592
250,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,88,Down,0.177156335196109,0.583198655465592
251,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.178407050670747,0.58497610638257
252,WP_GPCRS_CLASS_A_RHODOPSINLIKE,46,Down,0.18065392293324,0.589413340517611
253,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.181643314631126,0.589413340517611
254,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.18242348916322,0.589413340517611
255,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Up,0.183224128537904,0.589413340517611
256,WP_STEROID_BIOSYNTHESIS,3,Up,0.183341209201104,0.589413340517611
257,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.186862578383988,0.598396505875573
258,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.18794518319215,0.599250555742072
259,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.190167032209837,0.599250555742072
260,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.191274785261798,0.599250555742072
261,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.191883349224027,0.599250555742072
262,WP_IDO_METABOLIC_PATHWAY,8,Up,0.192985851355187,0.599250555742072
263,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.193092951551346,0.599250555742072
264,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,70,Down,0.193287213916772,0.599250555742072
265,WP_MALE_INFERTILITY,70,Up,0.193961780788023,0.599250555742072
266,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Up,0.19486256144933,0.599250555742072
267,WP_BLADDER_CANCER,29,Down,0.195313287531997,0.599250555742072
268,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,42,Down,0.196688491521649,0.599250555742072
269,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.196841462883175,0.599250555742072
270,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,28,Down,0.197314657156974,0.599250555742072
271,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.197323087006199,0.599250555742072
272,WP_CILIOPATHIES,129,Up,0.199359230070968,0.602788947937322
273,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,81,Down,0.200850208569581,0.602788947937322
274,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.201201034215676,0.602788947937322
275,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,58,Down,0.201890198460992,0.602788947937322
276,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.202150364071325,0.602788947937322
277,WP_VITAMIN_D_METABOLISM,6,Down,0.20299078674694,0.603109810443076
278,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,12,Down,0.203778395072387,0.603272011311419
279,WP_GLIOBLASTOMA_SIGNALING,70,Down,0.204740538771367,0.603947897522706
280,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.211859121253403,0.622714488541252
281,WP_ADIPOGENESIS,88,Down,0.213880105300269,0.625128794381931
282,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.215093542527429,0.625128794381931
283,WP_RAS_SIGNALING,121,Down,0.216095750926087,0.625128794381931
284,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.216207991479967,0.625128794381931
285,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.21647837958548,0.625128794381931
286,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.217951932581635,0.627183358442956
287,WP_ENDOMETRIAL_CANCER,49,Down,0.224422593793743,0.63940423268746
288,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.224598031759693,0.63940423268746
289,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Down,0.224694904711406,0.63940423268746
290,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.225582811655302,0.63940423268746
291,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.226083392116708,0.63940423268746
292,WP_HOMOLOGOUS_RECOMBINATION,12,Down,0.230009863014143,0.647188589828288
293,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,94,Down,0.231154379567773,0.647188589828288
294,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Down,0.231194951894917,0.647188589828288
295,WP_SPINA_BIFIDA,10,Down,0.234226318142033,0.653451728240315
296,WP_IL26_SIGNALING,33,Down,0.235248967629789,0.654087501213906
297,WP_OPIOID_RECEPTOR_PATHWAYS,26,Down,0.237902126061264,0.658748409838946
298,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.23886215683043,0.658748409838946
299,WP_ENDOCHONDRAL_OSSIFICATION,27,Down,0.240127002371426,0.658748409838946
300,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Down,0.240127002371426,0.658748409838946
301,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.240996697544369,0.658937814215998
302,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.244923268341058,0.663918588650727
303,WP_TCELL_RECEPTOR_SIGNALING,76,Down,0.245650092779855,0.663918588650727
304,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.246042694100322,0.663918588650727
305,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.246045163473234,0.663918588650727
306,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.24734086735844,0.665233770705869
307,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.250561089776492,0.671107588909894
308,WP_BASE_EXCISION_REPAIR,29,Down,0.251155695485112,0.671107588909894
309,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Down,0.254198607195913,0.675437866759143
310,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,19,Down,0.255059966434724,0.675437866759143
311,WP_SELENIUM_MICRONUTRIENT_NETWORK,53,Up,0.255238367633163,0.675437866759143
312,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.256270572040854,0.675995771761611
313,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,79,Down,0.258943430437641,0.680159219183605
314,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.259501816310634,0.680159219183605
315,WP_NRXN1_DELETION_SYNDROME,3,Up,0.261337606593828,0.682796349926097
316,WP_KALLMANN_SYNDROME,11,Up,0.263570966256171,0.685443398797975
317,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,16,Up,0.264016473170059,0.685443398797975
318,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.265124705399944,0.685500794257969
319,WP_AGERAGE_PATHWAY,54,Down,0.268070842584843,0.685500794257969
320,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Up,0.268843663310564,0.685500794257969
321,WP_OXIDATIVE_DAMAGE_RESPONSE,36,Up,0.272429211105269,0.685500794257969
322,WP_BDNFTRKB_SIGNALING,27,Down,0.27263268626578,0.685500794257969
323,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.273022708739693,0.685500794257969
324,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.273401658813583,0.685500794257969
325,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.273972374981622,0.685500794257969
326,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,21,Down,0.273990433532913,0.685500794257969
327,WP_RETT_SYNDROME,32,Down,0.274623865345131,0.685500794257969
328,WP_IL18_SIGNALING,198,Up,0.276549316085708,0.685500794257969
329,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,15,Down,0.276638052517185,0.685500794257969
330,WP_ALZHEIMERS_DISEASE,187,Down,0.276743335454938,0.685500794257969
331,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,187,Down,0.276743335454938,0.685500794257969
332,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.277231496360543,0.685500794257969
333,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Down,0.277706719424735,0.685500794257969
334,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.278265033547529,0.685500794257969
335,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,34,Down,0.279031307504763,0.685500794257969
336,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,85,Down,0.281563585891346,0.689586914599713
337,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Up,0.282715341054174,0.689586914599713
338,WP_OVARIAN_INFERTILITY,23,Down,0.284086377964673,0.689586914599713
339,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Up,0.284114474489461,0.689586914599713
340,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Down,0.285332507306552,0.689586914599713
341,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,88,Down,0.285721917227827,0.689586914599713
342,WP_DRAVET_SYNDROME,15,Down,0.286634283227278,0.689681201296698
343,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.287437001269462,0.689681201296698
344,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.28956449202726,0.690885886943591
345,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.289618020650716,0.690885886943591
346,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.291764842796451,0.692340414677254
347,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Up,0.293738463630791,0.692340414677254
348,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.293934218946083,0.692340414677254
349,WP_ENERGY_METABOLISM,41,Down,0.294446230846224,0.692340414677254
350,WP_FLUOROPYRIMIDINE_ACTIVITY,28,Up,0.29528047925509,0.692340414677254
351,WP_MTHFR_DEFICIENCY,18,Up,0.296548588954921,0.692340414677254
352,WP_PURINE_METABOLISM,10,Down,0.297169840202768,0.692340414677254
353,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.297770640486912,0.692340414677254
354,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.297798914697142,0.692340414677254
355,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Down,0.300552584176708,0.692453084312849
356,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Down,0.301228002763927,0.692453084312849
357,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,54,Down,0.301263802955996,0.692453084312849
358,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.301799272934325,0.692453084312849
359,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.303105230407571,0.692453084312849
360,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.303414958549498,0.692453084312849
361,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.303737015111711,0.692453084312849
362,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.306717567974687,0.697316459787754
363,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,75,Down,0.309179372401659,0.700976924205414
364,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.310698544300147,0.702485994392916
365,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Down,0.313636914566705,0.70718679640657
366,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.316866079902938,0.708257134150999
367,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.316951293038498,0.708257134150999
368,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.31725847984863,0.708257134150999
369,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.318118121008299,0.708257134150999
370,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.318414507455491,0.708257134150999
371,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.320925937538055,0.711919263056118
372,WP_JOUBERT_SYNDROME,72,Up,0.322311363341677,0.713070569973656
373,WP_PROLACTIN_SIGNALING,69,Down,0.328179444845382,0.724106389028819
374,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.329196208318191,0.724210738845673
375,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.329986667153253,0.724210738845673
376,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,130,Up,0.331925559435784,0.724969496473744
377,WP_CIRCADIAN_RHYTHM_GENES,124,Down,0.332094167886515,0.724969496473744
378,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,66,Up,0.336128295303386,0.731061819210994
379,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.336661518202876,0.731061819210994
380,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.337736142417545,0.73146538213063
381,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.341804170376541,0.7383328929656
382,WP_HIPPOYAP_SIGNALING,16,Down,0.343580220334447,0.738601785553282
383,WP_TAR_SYNDROME,46,Down,0.34372355269369,0.738601785553282
384,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Down,0.3479045905023,0.745639265581752
385,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.350557619968751,0.746407290228088
386,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.350765805889967,0.746407290228088
387,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.351890678746656,0.746407290228088
388,WP_HEME_BIOSYNTHESIS,8,Down,0.351890678746656,0.746407290228088
389,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.353105926544078,0.747059582379888
390,WP_ATR_SIGNALING,10,Up,0.356949732141598,0.750433213315505
391,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.358550301228282,0.750433213315505
392,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,114,Down,0.35880498017042,0.750433213315505
393,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.359087850103608,0.750433213315505
394,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,34,Down,0.360021828415136,0.750433213315505
395,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,64,Down,0.361076241015139,0.750433213315505
396,WP_TGFBETA_RECEPTOR_SIGNALING,37,Down,0.361083295835893,0.750433213315505
397,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.362763045155547,0.75202515406301
398,WP_TLR4_SIGNALING_AND_TOLERANCE,27,Down,0.364477918366106,0.75217759207969
399,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,12,Up,0.365352168489778,0.75217759207969
400,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.366451175645895,0.75217759207969
401,WP_ACUTE_VIRAL_MYOCARDITIS,69,Down,0.367402016193933,0.75217759207969
402,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.367406308646459,0.75217759207969
403,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.368933111765648,0.753429158767067
404,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,11,Up,0.370388734100134,0.754529525159432
405,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.3718438589971,0.754954069750075
406,WP_CHEMOKINE_SIGNALING,111,Down,0.372431776814739,0.754954069750075
407,WP_GLUTATHIONE_METABOLISM,12,Up,0.376160227930162,0.755489200837831
408,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,90,Down,0.376523810994389,0.755489200837831
409,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.376644176741985,0.755489200837831
410,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.377026928604197,0.755489200837831
411,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,14,Down,0.377285615485235,0.755489200837831
412,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.379254515987944,0.755501107219161
413,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,23,Up,0.379854742977746,0.755501107219161
414,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.380863834687021,0.755501107219161
415,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.381407794239212,0.755501107219161
416,WP_GALANIN_RECEPTOR_PATHWAY,12,Down,0.381881483114424,0.755501107219161
417,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Up,0.385514704574914,0.756792836877683
418,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.385673566937255,0.756792836877683
419,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.386296485540163,0.756792836877683
420,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,9,Down,0.386363336782421,0.756792836877683
421,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,40,Up,0.387975486707488,0.756792836877683
422,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.38805173409767,0.756792836877683
423,WP_SYNAPTIC_VESICLE_PATHWAY,24,Down,0.393129217696767,0.764882615045956
424,WP_G_PROTEIN_SIGNALING,62,Down,0.394925441515777,0.766220258531019
425,WP_SERINE_METABOLISM,7,Down,0.395678748330113,0.766220258531019
426,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,16,Down,0.398341750711639,0.769123305387547
427,WP_APOPTOSIS_MODULATION_AND_SIGNALING,80,Up,0.399046964034608,0.769123305387547
428,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,25,Up,0.40384113010701,0.772390500190835
429,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Down,0.403959690599392,0.772390500190835
430,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,8,Down,0.404693181840923,0.772390500190835
431,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.404753434090148,0.772390500190835
432,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.406580419381241,0.772390500190835
433,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Down,0.40786045104249,0.772390500190835
434,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.408738993581601,0.772390500190835
435,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.408753530678226,0.772390500190835
436,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.409188648946785,0.772390500190835
437,WP_AFLATOXIN_B1_METABOLISM,3,Up,0.411822076302482,0.775582537292775
438,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.415071043586025,0.778102691621288
439,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,26,Down,0.415990287277207,0.778102691621288
440,WP_CHOLESTASIS,9,Down,0.41743850108461,0.778102691621288
441,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.417531849116615,0.778102691621288
442,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.417887472292357,0.778102691621288
443,WP_7OXOC_AND_7BETAHC_PATHWAYS,18,Up,0.421544006948294,0.781056372794642
444,WP_IL10_ANTIINFLAMMATORY_SIGNALING,12,Up,0.424655344544502,0.781056372794642
445,WP_BLOOD_CLOTTING_CASCADE,10,Down,0.425516761659776,0.781056372794642
446,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,46,Up,0.426212345311614,0.781056372794642
447,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.426233252484605,0.781056372794642
448,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.426928334840123,0.781056372794642
449,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.426966608690999,0.781056372794642
450,WP_MELANOMA,55,Down,0.427066060458796,0.781056372794642
451,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.428694247258357,0.782295710628887
452,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,50,Down,0.431276283171759,0.783174663298149
453,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.431496990846998,0.783174663298149
454,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,34,Down,0.432030737712466,0.783174663298149
455,WP_CCL18_SIGNALING,22,Down,0.433154286395059,0.783485665281613
456,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,19,Down,0.434376968885706,0.78397422235293
457,WP_ONCOSTATIN_M_SIGNALING,56,Down,0.437720162612883,0.787992505904709
458,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Down,0.438518308267748,0.787992505904709
459,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.447043323496866,0.799970424289466
460,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.447128062178802,0.799970424289466
461,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Up,0.449199069607537,0.801932395416493
462,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,128,Down,0.453818733333829,0.808426011977796
463,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,61,Down,0.455586944183549,0.809823013095164
464,WP_CELL_CYCLE,100,Down,0.458260511827065,0.811189296205306
465,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.459242763833129,0.811189296205306
466,WP_VEGFAVEGFR2_SIGNALING,348,Down,0.459312529807621,0.811189296205306
467,WP_SMALL_CELL_LUNG_CANCER,73,Up,0.460887987298112,0.812025041561594
468,WP_RAC1PAK1P38MMP2_PATHWAY,53,Down,0.461759075881927,0.812025041561594
469,WP_TGFB_SMAD_SIGNALING,8,Up,0.466279754038391,0.812869484520848
470,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.466921748098426,0.812869484520848
471,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.46762911678967,0.812869484520848
472,WP_ENDODERM_DIFFERENTIATION,85,Down,0.467684568349824,0.812869484520848
473,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Up,0.467869236846262,0.812869484520848
474,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,100,Up,0.468165413928168,0.812869484520848
475,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,55,Down,0.469157966694379,0.812877908609419
476,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.470316306126054,0.813172941054081
477,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.472679678164243,0.815545859809586
478,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.475823598618005,0.819252764984556
479,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,14,Up,0.478251017437424,0.819344850583879
480,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Up,0.478903388727913,0.819344850583879
481,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.47906102188244,0.819344850583879
482,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.479859317109878,0.819344850583879
483,WP_KCNQ2RELATED_EPILEPSIES,12,Up,0.481083225205434,0.81973394274135
484,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.484201983645192,0.82164919120325
485,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,17,Down,0.484456053814008,0.82164919120325
486,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.485829846331965,0.82164919120325
487,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.486200675718084,0.82164919120325
488,WP_OXIDATION_BY_CYTOCHROME_P450,16,Up,0.489004485682585,0.823796159681604
489,WP_PHOSPHOINOSITIDES_METABOLISM,39,Down,0.490382227080861,0.823796159681604
490,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.491921537631561,0.823796159681604
491,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Down,0.492424039495818,0.823796159681604
492,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.492475954511967,0.823796159681604
493,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,45,Down,0.495577281495949,0.827302439495267
494,WP_HIPPO_SIGNALING_REGULATION,46,Down,0.497965914263879,0.828370124303594
495,WP_VITAMIN_D_RECEPTOR_PATHWAY,86,Down,0.498717075299979,0.828370124303594
496,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.499959229246849,0.828370124303594
497,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.500242954773859,0.828370124303594
498,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.503046207006729,0.830450929048065
499,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,27,Up,0.504135015504284,0.830450929048065
500,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.504526688364559,0.830450929048065
501,WP_ASPIRIN_AND_MIRNAS,8,Down,0.50893291237186,0.836031510742596
502,WP_HUNGER_AND_SATIETY,2,Up,0.510013727088675,0.83613804261749
503,WP_RANKLRANK_SIGNALING,49,Up,0.51241470290706,0.83651101972312
504,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,25,Down,0.513119543049306,0.83651101972312
505,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.514051717461375,0.83651101972312
506,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,13,Up,0.514306896694895,0.83651101972312
507,WP_PROTEASOME_DEGRADATION,57,Down,0.516312360866075,0.837324907134385
508,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.51751501494879,0.837324907134385
509,WP_TNFALPHA_SIGNALING,86,Down,0.518605035836603,0.837324907134385
510,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,75,Down,0.518876916936253,0.837324907134385
511,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,14,Down,0.520056365684956,0.837585888373226
512,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.522567044436797,0.838824622425883
513,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Down,0.522863950552221,0.838824622425883
514,WP_SILDENAFIL_TREATMENT,12,Up,0.526439699166742,0.841743694022815
515,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.526729043039793,0.841743694022815
516,WP_TCELL_ACTIVATION_SARSCOV2,64,Up,0.528618279352563,0.843125666486742
517,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Up,0.532541003168717,0.845017480314421
518,WP_13Q1212_COPY_NUMBER_VARIATION,21,Up,0.532940797515703,0.845017480314421
519,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.533751643888173,0.845017480314421
520,WP_METABOLIC_EPILEPTIC_DISORDERS,59,Down,0.533911409190157,0.845017480314421
521,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Up,0.537736923154655,0.847884677495134
522,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,12,Down,0.53778347709898,0.847884677495134
523,WP_IL4_SIGNALING,51,Down,0.53897347311056,0.848136077189276
524,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.54118945911899,0.849997948196429
525,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Up,0.542586895099597,0.850569551746606
526,WP_NEPHROGENESIS,4,Up,0.545297141544609,0.852285986743394
527,WP_DNA_DAMAGE_RESPONSE,60,Down,0.546010560731655,0.852285986743394
528,WP_IL17_SIGNALING,25,Up,0.548307036472771,0.852285986743394
529,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.549266517668631,0.852285986743394
530,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Down,0.549407049849268,0.852285986743394
531,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.54989533288061,0.852285986743394
532,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,20,Down,0.553407799208379,0.855736415688496
533,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,23,Down,0.554201105178576,0.855736415688496
534,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Up,0.556800185188907,0.858139611255562
535,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Down,0.558232938855123,0.858739642388349
536,WP_TRANSSULFURATION_PATHWAY,8,Down,0.561655235373348,0.862392273716912
537,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.563225291979945,0.863192579701108
538,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.564624453067874,0.86372848489751
539,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.567946370062956,0.867198260782584
540,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,32,Up,0.570946196877648,0.870164296352415
541,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.574916020902686,0.874594981890778
542,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,42,Up,0.576093219763743,0.874768855840517
543,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.582536092945594,0.882923028534482
544,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.585316032068433,0.883780566106018
545,WP_4P163_COPY_NUMBER_VARIATION,22,Down,0.58535840908353,0.883780566106018
546,WP_KREBS_CYCLE_DISORDERS,11,Down,0.586323437538136,0.883780566106018
547,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.589499210857683,0.88449722981965
548,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.590023060961103,0.88449722981965
549,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.590023060961103,0.88449722981965
550,WP_PREGNANE_X_RECEPTOR_PATHWAY,14,Up,0.59636917481698,0.890228666332721
551,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.597892666212171,0.890228666332721
552,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.600759492834587,0.890228666332721
553,WP_LUNG_PATHOLOGY_OF_COVID19,17,Down,0.601934805152511,0.890228666332721
554,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,49,Up,0.602955295756989,0.890228666332721
555,WP_ALSTROM_SYNDROME,27,Down,0.604547603050358,0.890228666332721
556,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.60541508225755,0.890228666332721
557,WP_OSTEOCLAST_SIGNALING,9,Down,0.605647663482976,0.890228666332721
558,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.606023294216882,0.890228666332721
559,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.606023294216882,0.890228666332721
560,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Down,0.607402918328927,0.890228666332721
561,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.607449157575058,0.890228666332721
562,WP_EFFECTS_OF_MFN2_MUTATION,18,Down,0.609520649032545,0.890228666332721
563,WP_ULCERATIVE_COLITIS_SIGNALING,13,Up,0.609659854475202,0.890228666332721
564,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,27,Down,0.610071649831901,0.890228666332721
565,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.614545704567984,0.892747020192795
566,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,67,Down,0.615183026545902,0.892747020192795
567,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.615288459026789,0.892747020192795
568,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.618922968455064,0.892747020192795
569,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.619694493822162,0.892747020192795
570,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.619903234466613,0.892747020192795
571,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.62053500746714,0.892747020192795
572,WP_FOXA2_PATHWAY,10,Up,0.621826121972396,0.892747020192795
573,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.622370389040553,0.892747020192795
574,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,39,Down,0.622644944824623,0.892747020192795
575,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.623738060309416,0.892758997625477
576,WP_IL7_SIGNALING,23,Up,0.6298417319903,0.896039242537506
577,WP_MEASLES_VIRUS_INFECTION,104,Up,0.630048385488686,0.896039242537506
578,WP_RETINOBLASTOMA_GENE_IN_CANCER,76,Down,0.630752746607626,0.896039242537506
579,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.631021270904511,0.896039242537506
580,WP_VITAMIN_B12_DISORDERS,9,Up,0.632987738613135,0.896039242537506
581,WP_ACUTE_MYELOID_LEUKEMIA,57,Up,0.633573364442471,0.896039242537506
582,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,13,Up,0.633651080384967,0.896039242537506
583,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.637756782217364,0.899782108889831
584,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.638520198025733,0.899782108889831
585,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,147,Up,0.639577805225457,0.899782108889831
586,WP_KIT_RECEPTOR_SIGNALING,53,Down,0.643340164653634,0.901365516767166
587,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,17,Down,0.643456366521541,0.901365516767166
588,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.645701899888384,0.901365516767166
589,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,16,Down,0.646142050122715,0.901365516767166
590,WP_METHYLATION_PATHWAYS,5,Up,0.646732456297816,0.901365516767166
591,WP_TRANSLATION_FACTORS,49,Down,0.647708824071232,0.901365516767166
592,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,52,Up,0.648569142359843,0.901365516767166
593,WP_CELLULAR_PROTEOSTASIS,6,Up,0.649465068581931,0.901365516767166
594,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Up,0.650950050298072,0.901905541069551
595,WP_IL3_SIGNALING,46,Up,0.659272451579782,0.911146960646903
596,WP_SLEEP_REGULATION,11,Down,0.659834250966652,0.911146960646903
597,WP_ARYLAMINE_METABOLISM,1,Up,0.663162400952333,0.914208803992915
598,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.665012715065434,0.914460785535277
599,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,14,Down,0.665567449010487,0.914460785535277
600,WP_ALLOGRAFT_REJECTION,53,Up,0.667042862636591,0.914737979870498
601,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Down,0.667992133538481,0.914737979870498
602,WP_NUCLEAR_RECEPTORS_METAPATHWAY,184,Up,0.672529055829337,0.91783839903398
603,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,33,Down,0.674681383579975,0.91783839903398
604,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.675356120399586,0.91783839903398
605,WP_CORI_CYCLE,11,Down,0.676039602464152,0.91783839903398
606,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.677381486747542,0.91783839903398
607,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.677890072438033,0.91783839903398
608,WP_ATM_SIGNALING,35,Up,0.678934202801928,0.91783839903398
609,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.67917811058529,0.91783839903398
610,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.685305801343961,0.920075308630573
611,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.68668990033195,0.920075308630573
612,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,51,Down,0.687985845344244,0.920075308630573
613,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.689352614397192,0.920075308630573
614,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.689579755080343,0.920075308630573
615,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.690641039524706,0.920075308630573
616,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,23,Up,0.693241401272834,0.920075308630573
617,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,50,Up,0.693862032031742,0.920075308630573
618,WP_ENDOTHELIN_PATHWAYS,13,Down,0.693905476407481,0.920075308630573
619,WP_ID_SIGNALING,12,Down,0.694484655671135,0.920075308630573
620,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.697601240856607,0.920075308630573
621,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.697919142416787,0.920075308630573
622,WP_IL5_SIGNALING,37,Down,0.698459430691577,0.920075308630573
623,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.698589510338519,0.920075308630573
624,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.698816793897558,0.920075308630573
625,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.700008514439013,0.920075308630573
626,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.700176692889823,0.920075308630573
627,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.702113538973117,0.920075308630573
628,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,19,Up,0.703315865140583,0.920075308630573
629,WP_NONSMALL_CELL_LUNG_CANCER,61,Down,0.703534603138762,0.920075308630573
630,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Down,0.705236148562135,0.920075308630573
631,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Down,0.706451966781987,0.920075308630573
632,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.706546288037086,0.920075308630573
633,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,10,Up,0.71127895450064,0.920855176888666
634,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.711911173830026,0.920855176888666
635,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.712356534888465,0.920855176888666
636,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Down,0.713951547084874,0.920855176888666
637,WP_ESTROGEN_METABOLISM_WP697,6,Up,0.714318928476536,0.920855176888666
638,WP_ONECARBON_METABOLISM,23,Down,0.714702965353986,0.920855176888666
639,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.714977470269572,0.920855176888666
640,WP_UROTENSINIIMEDIATED_SIGNALING,50,Down,0.71739228816873,0.922521645566976
641,WP_MONOAMINE_TRANSPORT,12,Down,0.723605920891634,0.927890967042378
642,WP_IL6_SIGNALING,40,Down,0.723982077518256,0.927890967042378
643,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Down,0.72738095011664,0.927890967042378
644,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.727409042009298,0.927890967042378
645,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Down,0.72832301793699,0.927890967042378
646,WP_ANGIOGENESIS,15,Up,0.729114881720809,0.927890967042378
647,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,78,Down,0.72945984893854,0.927890967042378
648,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,36,Up,0.732440592261184,0.928009071225845
649,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.733186102220418,0.928009071225845
650,WP_INTEGRATED_CANCER_PATHWAY,41,Down,0.735345934312558,0.928009071225845
651,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,42,Down,0.73608366641372,0.928009071225845
652,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.736111927409359,0.928009071225845
653,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.736318254569231,0.928009071225845
654,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,41,Down,0.73970457537506,0.930851476351184
655,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,51,Up,0.741612571423543,0.931182483174124
656,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,17,Down,0.743047980219951,0.931182483174124
657,WP_CYTOSOLIC_DNASENSING_PATHWAY,55,Down,0.743361958013851,0.931182483174124
658,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.748391801982906,0.935635062733397
659,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.749190165663802,0.935635062733397
660,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.75085746451996,0.936296504999889
661,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.752992863925992,0.937236754884408
662,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.754537838411491,0.937236754884408
663,WP_CREATINE_PATHWAY,3,Down,0.756125702140404,0.937236754884408
664,WP_TP53_NETWORK,16,Up,0.756681026494596,0.937236754884408
665,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.757305518831266,0.937236754884408
666,WP_EICOSANOID_SYNTHESIS,14,Down,0.762564332916704,0.942327996982653
667,WP_PI3KAKT_SIGNALING,186,Up,0.76443689211746,0.943225730453778
668,WP_GPR40_PATHWAY,10,Up,0.76677942189865,0.944288637104747
669,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,30,Down,0.767681678441157,0.944288637104747
670,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,4,Up,0.768740445759636,0.944288637104747
671,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.772755722300481,0.947284125324706
672,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.773481084104741,0.947284125324706
673,WP_IL2_SIGNALING,37,Down,0.776399243840789,0.948471468814674
674,WP_MRNA_PROCESSING,124,Down,0.776755492079089,0.948471468814674
675,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Up,0.782440558820451,0.950039948027612
676,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,67,Down,0.783071373656531,0.950039948027612
677,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.783152405535472,0.950039948027612
678,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.783235534238765,0.950039948027612
679,WP_GLYOXYLATE_METABOLISM,5,Down,0.783811816173449,0.950039948027612
680,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.786775076258758,0.952229246707291
681,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Down,0.789302525122818,0.953885430508193
682,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.790841536567199,0.954057311421807
683,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.792887116144625,0.954057311421807
684,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.792922479966605,0.954057311421807
685,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,41,Up,0.798673759498718,0.958003122779017
686,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Up,0.802689454964124,0.958003122779017
687,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,4,Up,0.803561024306774,0.958003122779017
688,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.803920957078446,0.958003122779017
689,WP_CANCER_PATHWAYS,320,Down,0.804043510256344,0.958003122779017
690,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.804243355162836,0.958003122779017
691,WP_IL19_SIGNALING,20,Down,0.804967294540828,0.958003122779017
692,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,35,Down,0.807676349615724,0.958003122779017
693,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.808123802030301,0.958003122779017
694,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.810012187587738,0.958003122779017
695,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,31,Up,0.812027081449136,0.958003122779017
696,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,22,Down,0.812207311374223,0.958003122779017
697,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.812390332733889,0.958003122779017
698,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.812498395746967,0.958003122779017
699,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.81448330744457,0.958969616633592
700,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,35,Up,0.81926083975634,0.962806928494431
701,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.82058223230877,0.962806928494431
702,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.825138323437313,0.962806928494431
703,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.826044597602887,0.962806928494431
704,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.826698589196558,0.962806928494431
705,WP_NUCLEOTIDE_GPCRS,6,Up,0.827603458229812,0.962806928494431
706,WP_SULFATASE_AND_AROMATASE_PATHWAY,4,Down,0.829155796367052,0.962806928494431
707,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.830860439956967,0.962806928494431
708,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.831090083994594,0.962806928494431
709,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.832005443538712,0.962806928494431
710,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.832431201230128,0.962806928494431
711,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.832991132950703,0.962806928494431
712,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.833265777680323,0.962806928494431
713,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,4,Down,0.834120704758844,0.962806928494431
714,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Down,0.839214481359481,0.966460820660415
715,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.839634856345318,0.966460820660415
716,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,74,Down,0.841196032094784,0.96690549499163
717,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Up,0.845695386746136,0.970721482973599
718,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,280,Up,0.848221557710479,0.971608510965003
719,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.850434440046339,0.971608510965003
720,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Down,0.850465480058612,0.971608510965003
721,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,6,Down,0.852384425713143,0.971608510965003
722,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.853731278653317,0.971608510965003
723,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.853811019520352,0.971608510965003
724,WP_GLUCURONIDATION,7,Down,0.855590037242401,0.971608510965003
725,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Down,0.855912722296023,0.971608510965003
726,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.858049287358687,0.972410680395666
727,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,20,Up,0.861791871346496,0.972410680395666
728,WP_ESTROGEN_SIGNALING,21,Down,0.861834083969851,0.972410680395666
729,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,171,Up,0.863475924320023,0.972410680395666
730,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.864309299363737,0.972410680395666
731,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,11,Down,0.865580573596863,0.972410680395666
732,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,21,Up,0.865816362647396,0.972410680395666
733,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.866166606690416,0.972410680395666
734,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.86759315197909,0.972410680395666
735,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Up,0.868434811774987,0.972410680395666
736,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.872589518646677,0.974621281576078
737,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.875122282720259,0.974621281576078
738,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.875350945741848,0.974621281576078
739,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,16,Down,0.875747397542486,0.974621281576078
740,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.877235532122066,0.974621281576078
741,WP_DNA_REPLICATION,37,Down,0.878682827658027,0.974621281576078
742,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.878698652405164,0.974621281576078
743,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,12,Down,0.882006032942749,0.976973035143853
744,WP_RETINOL_METABOLISM,7,Up,0.883456462134377,0.977264339162087
745,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.885052864464028,0.977716117387779
746,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,22,Up,0.886864700168231,0.978404354207044
747,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.888312595100123,0.978689780143777
748,WP_BURN_WOUND_HEALING,63,Down,0.890023464086633,0.978868198314635
749,WP_CILIARY_LANDSCAPE,186,Down,0.891215139591044,0.978868198314635
750,WP_TOLLLIKE_RECEPTOR_SIGNALING,82,Up,0.892042708063154,0.978868198314635
751,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Up,0.89665775445712,0.97900619716251
752,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.897272251889072,0.97900619716251
753,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.90038191708274,0.97900619716251
754,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.901474597196174,0.97900619716251
755,WP_PURINERGIC_SIGNALING,16,Down,0.902060970678638,0.97900619716251
756,WP_MIRNA_BIOGENESIS,6,Down,0.902110890908683,0.97900619716251
757,WP_VALPROIC_ACID_PATHWAY,9,Down,0.903619488763965,0.97900619716251
758,WP_MESODERMAL_COMMITMENT_PATHWAY,79,Up,0.904177964081949,0.97900619716251
759,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.905335324755135,0.97900619716251
760,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,38,Up,0.906106095280179,0.97900619716251
761,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.906645865168998,0.97900619716251
762,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.910149683034268,0.97900619716251
763,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.91133422990867,0.97900619716251
764,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.91249328116484,0.97900619716251
765,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.91273191757652,0.97900619716251
766,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.914799369501601,0.97900619716251
767,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,38,Up,0.916844446084863,0.97900619716251
768,WP_ALPHA_6_BETA_4_SIGNALING,27,Down,0.916997260725498,0.97900619716251
769,WP_IL11_SIGNALING,41,Up,0.917492170402202,0.97900619716251
770,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.917529990086119,0.97900619716251
771,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.918707512651101,0.97900619716251
772,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.918861064961356,0.97900619716251
773,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,22,Down,0.919608747854638,0.97900619716251
774,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.92071785735575,0.97900619716251
775,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.927558900361859,0.985007709674594
776,WP_AUTOPHAGY,27,Down,0.930354620801567,0.986627883155033
777,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.932719486883699,0.986627883155033
778,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.93483788984472,0.986627883155033
779,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.939297090348886,0.986627883155033
780,WP_LUNG_FIBROSIS,35,Up,0.94083212628835,0.986627883155033
781,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.941350790925823,0.986627883155033
782,WP_PRION_DISEASE_PATHWAY,28,Down,0.942140275901125,0.986627883155033
783,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.94235224733205,0.986627883155033
784,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.943057752793411,0.986627883155033
785,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Down,0.944237308927549,0.986627883155033
786,WP_NEPHROTIC_SYNDROME,29,Up,0.944516111132985,0.986627883155033
787,WP_FOXP3_IN_COVID19,10,Down,0.945836000419949,0.986627883155033
788,WP_AEROBIC_GLYCOLYSIS,10,Up,0.947361513423024,0.986627883155033
789,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.947361513423024,0.986627883155033
790,WP_CAMKK2_PATHWAY,30,Up,0.947709699242159,0.986627883155033
791,WP_DNA_MISMATCH_REPAIR,21,Down,0.948638182308958,0.986627883155033
792,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,49,Up,0.95271527082717,0.986627883155033
793,WP_ECTODERM_DIFFERENTIATION,80,Down,0.952963529997467,0.986627883155033
794,WP_PREIMPLANTATION_EMBRYO,22,Down,0.9533358158205,0.986627883155033
795,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,9,Up,0.953624429042038,0.986627883155033
796,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.954259775202195,0.986627883155033
797,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.956658682335423,0.987222522475011
798,WP_APOPTOSIS,74,Up,0.95723398898549,0.987222522475011
799,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,24,Up,0.963480890185453,0.991560105175133
800,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.964849906284965,0.991560105175133
801,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.965054245741533,0.991560105175133
802,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,50,Up,0.969676925619089,0.991958340745945
803,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,25,Down,0.970599833835317,0.991958340745945
804,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.972924984265678,0.991958340745945
805,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.973890807991953,0.991958340745945
806,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.974275117737219,0.991958340745945
807,WP_PRIMARY_OVARIAN_INSUFFICIENCY,95,Down,0.975433660019734,0.991958340745945
808,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Down,0.979120952512743,0.991958340745945
809,WP_THERMOGENESIS,75,Up,0.979173263387739,0.991958340745945
810,WP_NETRINUNC5B_SIGNALING,36,Down,0.97970490992928,0.991958340745945
811,WP_PYRIMIDINE_METABOLISM,75,Down,0.980068856514618,0.991958340745945
812,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.980335694319321,0.991958340745945
813,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.980957523321357,0.991958340745945
814,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,40,Down,0.981110679668528,0.991958340745945
815,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Up,0.983081037703402,0.992730912920122
816,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.984643309309133,0.993090004364481
817,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.988910276980598,0.996172775954751
818,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,31,Down,0.991341443132974,0.997400987406403
819,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.994999829572066,0.999517726449701
820,WP_OSTEOPONTIN_SIGNALING,11,Down,0.997157913388386,0.999517726449701
821,WP_5Q35_COPY_NUMBER_VARIATION,78,Down,0.998360432938224,0.999517726449701
822,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,182,Down,0.998489273306118,0.999517726449701
823,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,14,Up,0.999517726449701,0.999517726449701
